top of page

Who We Are

A science and technology company
We bring neuroscience to the point of work

Our Story

SOBEREYE was founded on a single conviction: that the neurological condition of a worker at the moment work begins is measurable — and that measuring it changes everything.​

 

We applied the science. We filed the patents. We validated the technology independently. And we built OPTOVERA — the platform that brings that science to the point of work, before every shift, in safety-critical operations across more than ten countries.​

 

That conviction became a technology. That technology is saving lives.​

​​

The Science

The Pupillary Light Reflex, the pupil's reaction to changes in light conditions,  is one of the most studied physiological signals in neuroscience. Its relationship to neurological condition — fatigue, sleep deprivation, medications, stress — is well established, extensively validated, and impossible to fake.​

 

We built the technology to bring that science outside clinical settings. A proprietary opaque enclosure combining a configured smartphone with precisely controlled light, making reliable PLR measurement possible in a mine, on a loading dock, at the start of a shift. We filed for patents, founded the company, and collaborated with researchers at the University of Naples Federico II to independently validate the approach. The resulting peer-reviewed study confirmed that our smartphone-based methodology captures PLR with sufficient accuracy for reliable pupillometry — and that the approach is safe per international ophthalmic instrument standards ISO 15004-2.2 and ANSI Z80.36.​

 

Our first MVP launched in March 2018. First purchase order followed within months.​

Pupillary Light Reflex Illustration
The OPTOVERA device, a compact smartphone-based headset used to measure pupillary light reflex for pre-shift neurological ass
Mining worker in hard hat and high-visibility vest using the OPTOVERA device at an open-pit mine site before starting a shift

OPTOVERA

SOBEREYE remains the science and technology company. OPTOVERA — introduced in 2024 — is the workforce readiness platform built on our neurological measurement technology. It is how our science reaches the people who need it.​

 

Explore OPTOVERA → optovera.com

What We Believe

Measurement beats estimation. Every system that relies on schedules, declarations, or observations is estimating the worker's condition. Objective measurement is not a feature — it is the minimum standard for a safety system that deserves to be trusted.

The most important moment in a shift is before it begins. Once a worker is operating heavy machinery or driving a loaded vehicle, the window for prevention has closed. Everything we build is designed for the moment before work begins.

Science that cannot reach the field cannot save lives. The relationship between pupillary response and neurological condition was established in laboratories decades before SOBEREYE brought it to the point of work. Closing the gap between scientific knowledge and operational application is the reason we exist.

Privacy and safety are not in tension. Sensitive physiological data belongs to the worker and the organization — not to us. Privacy by design is not a compliance position. It is an ethical one.

How We Work

Patent-protected IP. Our core measurement methodology is protected by US Patents 9,888,845 and 10,070,787 — covering the application of pupillary response analysis to workforce condition assessment at the point of work.

Peer-reviewed science. Our smartphone-based pupillometry methodology has been independently validated in a peer-reviewed study confirming measurement accuracy and eye safety per international ophthalmic instrument standards ISO 15004-2.2 and ANSI Z80.36.

ISO 27001 Certified. SOBEREYE operates under ISO/IEC 27001 certification — ensuring that data generated across every OPTOVERA deployment is handled with the highest standards of security and privacy.​

Our mission
Prevent workplace accidents

Fatigue, sleep deprivation, stress, medications — these factors degrade neurological condition long before any visible sign appears. By the time a supervisor notices something is wrong, the risk has already been present for hours.

Most safety systems track what workers do. None of them measure what is actually happening inside the worker at the moment work begins.

That is the gap SOBEREYE exists to close.

Every shift. Every worker. Every time.

Antonio Visconti, CEO and Founder of SOBEREYE Inc.

Antonio Visconti

CEO/Founder​​

  • LinkedIn

Leadership team

Giovanni Mancini PhD, Chief Technology Officer SOBEREYE INC.

Giovanni Mancini PhD

CTO

Felipe De La Fuente, VP of Sales LATAM, SOBEREYE INC.

Felipe De La Fuente

VP Sales LATAM

Everton Pereira, Sales Director Brazil, SOBEREYE INC.

Everton Pereira

Sales Director Brazil

Davi Duchen, Customer Success Manager, SOBEREYE INC.

David Duchen

Customer Success Mgr. 

Press inquiries, investor relations, partnership discussions, or general corporate inquiries

There was a technical issue on our end. Try again or refresh.

© 2015- 2026  SOBEREYE INC. (Patent protected: US 9,888,845 - US 10,070,787)

  • LinkedIn Social Icon
bottom of page